Adenovirus as a new agent for multiple myeloma therapies: Opportunities and restrictions

Multiple myeloma is a malignancy of B-cells that is characterized by the clonal expansion and accumulation of malignant plasma cells in the bone marrow. This disease remains incurable, and a median survival of 3-5 years has been reported with the use of current treatments. Viral-based therapies offe...

Descripción completa

Detalles Bibliográficos
Autores principales: Raus, Svjetlana, Coin, Silvia, Monsurrò, Vladia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259514/
https://www.ncbi.nlm.nih.gov/pubmed/22259628
http://dx.doi.org/10.5045/kjh.2011.46.4.229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259514/
https://www.ncbi.nlm.nih.gov/pubmed/22259628
http://dx.doi.org/10.5045/kjh.2011.46.4.229

Ejemplares similares